Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • Volasertib - Leukemia, Myelomonocytic, Chronic
    Clinical Study Number 1230.35
    Study Indication Leukemia, Myelomonocytic, Chronic
    Product Volasertib
    Generic Name Volasertib
    Lab Code BI 6727
    Clinical Phase I
    Study Title

    An open label Phase I trial of intravenous volasertib in combination with subcutaneous azacitidine in Japanese patients with higher-risk myelodysplastic syndrome or chronic myelomonocytic leukemia

    Study Document
    Trial synopsis 1230.35 english